iNOVA4Health partners iBET and IPO team-up with Abbvie to improve predictivity of ex-vivo tumour models
17/09/2021
Researchers from iNOVA4Health partners iBET and IPOLFG, in collaboration with researchers from AbbVie have been investigating the development of innovative and predictive three-dimensional (3D) cell models